22nd Century Shares Outstanding 2011-2025 | XXII
22nd Century shares outstanding from 2011 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
22nd Century Annual Shares Outstanding
(Millions of Shares) |
| 2024 |
0 |
| 2023 |
0 |
| 2022 |
0 |
| 2021 |
156 |
| 2020 |
139 |
| 2019 |
126 |
| 2018 |
124 |
| 2017 |
101 |
| 2016 |
80 |
| 2015 |
68 |
| 2014 |
60 |
| 2013 |
44 |
| 2012 |
30 |
| 2011 |
26 |
| 2010 |
12 |
22nd Century Quarterly Shares Outstanding
(Millions of Shares) |
| 2025-03-31 |
0 |
| 2024-12-31 |
0 |
| 2024-09-30 |
0 |
| 2024-06-30 |
0 |
| 2024-03-31 |
0 |
| 2023-12-31 |
0 |
| 2023-09-30 |
0 |
| 2023-06-30 |
0 |
| 2023-03-31 |
0 |
| 2022-12-31 |
0 |
| 2022-09-30 |
0 |
| 2022-06-30 |
0 |
| 2022-03-31 |
163 |
| 2021-12-31 |
156 |
| 2021-09-30 |
163 |
| 2021-06-30 |
155 |
| 2021-03-31 |
144 |
| 2020-12-31 |
139 |
| 2020-09-30 |
139 |
| 2020-06-30 |
139 |
| 2020-03-31 |
139 |
| 2019-12-31 |
126 |
| 2019-09-30 |
125 |
| 2019-06-30 |
125 |
| 2019-03-31 |
125 |
| 2018-12-31 |
124 |
| 2018-09-30 |
144 |
| 2018-06-30 |
124 |
| 2018-03-31 |
144 |
| 2017-12-31 |
101 |
| 2017-09-30 |
101 |
| 2017-06-30 |
92 |
| 2017-03-31 |
91 |
| 2016-12-31 |
80 |
| 2016-09-30 |
80 |
| 2016-06-30 |
76 |
| 2016-03-31 |
74 |
| 2015-12-31 |
68 |
| 2015-09-30 |
71 |
| 2015-06-30 |
67 |
| 2015-03-31 |
64 |
| 2014-12-31 |
60 |
| 2014-09-30 |
60 |
| 2014-06-30 |
59 |
| 2014-03-31 |
58 |
| 2013-12-31 |
44 |
| 2013-09-30 |
47 |
| 2013-06-30 |
40 |
| 2013-03-31 |
36 |
| 2012-12-31 |
30 |
| 2012-09-30 |
31 |
| 2012-06-30 |
29 |
| 2012-03-31 |
28 |
| 2011-12-31 |
26 |
| 2011-09-30 |
27 |
| 2011-06-30 |
27 |
| 2011-03-31 |
24 |
| 2010-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Consumer Staples |
Tobacco Products |
$0.002B |
$0.024B |
|
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company's products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
|
